James Paul Rickey - 07 May 2024 Form 4 Insider Report for ALPINE IMMUNE SCIENCES, INC.

Signature
/s/ James Paul Rickey
Issuer symbol
N/A
Transactions as of
07 May 2024
Net transactions value
+$161,629
Form type
4
Filing time
09 May 2024, 21:13:07 UTC
Previous filing
29 Jan 2024
Next filing
20 May 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALPN Common Stock Options Exercise $7.55 +1 +0% $7.55* 31,201 07 May 2024 Direct F1
transaction ALPN Common Stock Options Exercise $93,126 +7,055 +23% $13.20* 38,256 07 May 2024 Direct
transaction ALPN Common Stock Options Exercise $5,579 +857 +2.2% $6.51* 39,113 07 May 2024 Direct
transaction ALPN Common Stock Options Exercise $1,855 +164 +0.42% $11.31* 39,277 07 May 2024 Direct
transaction ALPN Common Stock Options Exercise $59,064 +18,286 +47% $3.23 57,563 07 May 2024 Direct
transaction ALPN Common Stock Options Exercise $1,998 +398 +0.69% $5.02* 57,961 07 May 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALPN Stock Option (Right to buy) Options Exercise $0 -1 -0% $0.000000 108,999 07 May 2024 Common Stock 1 $7.55 Direct F2, F3
transaction ALPN Stock Option (Right to buy) Options Exercise $0 -7,055 -5.9% $0.000000 112,945 07 May 2024 Common Stock 7,055 $13.20 Direct F2, F4
transaction ALPN Stock Option (Right to buy) Options Exercise $0 -857 -86% $0.000000 143 07 May 2024 Common Stock 857 $6.51 Direct F2, F5
transaction ALPN Stock Option (Right to buy) Options Exercise $0 -164 -16% $0.000000 836 07 May 2024 Common Stock 164 $11.31 Direct F2, F6
transaction ALPN Stock Option (Right to buy) Options Exercise $0 -18,286 -94% $0.000000 1,214 07 May 2024 Common Stock 18,286 $3.23 Direct F2, F7
transaction ALPN Stock Option (Right to buy) Options Exercise $0 -398 -74% $0.000000 137 07 May 2024 Common Stock 398 $5.02 Direct F2, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 31,200 shares of common stock underlying a restricted stock unit grant made on January 4, 2024.
F2 The exercise price is equal to the closing price per share of Common Stock as reported on the Nasdaq Global Market on the date of grant.
F3 One-fourth (1/4th) of the Shares subject to the Option will vest on January 4, 2024, and one thirty-sixth (1/36th) of the remaining Shares subject to the Option shall vest each month thereafter, subject to the Reporting Person continuing to be a service provider through each such date.
F4 Twenty-five percent (25%) of the shares subject to the Option shall vest on the one (1) year anniversary of January 5, 2021 (the "Vesting Commencement Date") and one forty-eighth (1/48th) of the shares subject to the Option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month), subject to the Reporting Person continuing to be a Service Provider through each such date.
F5 100% of the shares underlying the option were fully vested as of February 6, 2023.
F6 100% of the shares underlying the option were fully vested as of January 2, 2022.
F7 100% of the shares underlying the option were fully vested as of January 23, 2024.
F8 100% of shares underlying the option were fully vested as of April 1, 2021.

Remarks:

Senior Vice President, Chief Financial Officer and Corporate Secretary